Skip to content
Contact us

The Guides

Sharing Expertise Through High-Value Papers

In an era where information is abundant yet deciphering quality knowledge remains a challenge, our team at preciSYN recognizes the imperative need to distill and share our deep-seated expertise through the creation of high-value papers. The rationale behind this initiative stems from our commitment to not only advance the frontier of precision medicine but also to illuminate the pathway for our customers to grasp the complex landscape in which we operate.

The precision medicine market is rapidly evolving, fueled by technological advancements and the increasing demand for personalized healthcare solutions. Within this dynamic environment, the expertise of preciSYN consultants emerges as a crucial asset for our clients. Our team’s proficiency spans across various domains, including digital health technologies, management consulting, business strategy innovation, and the intricacies of using data for enhancing clinical trials. This breadth of knowledge positions us uniquely to offer insights that are both pioneering and pragmatic.

The purpose of condensing our knowledge into high-value papers is twofold. Firstly, it allows us to articulate the context of our work, shedding light on the challenges and opportunities that define the precision medicine landscape. By providing a coherent narrative, we aim to enable our clients to better navigate this complex domain, making informed decisions that align with their strategic objectives. Secondly, these papers serve as a testament to the expertise of preciSYN consultants, demonstrating our ability to not only understand the nuances of the market but to also foresee trends and provide guidance that is actionable and forward-thinking.

Request a New Guide Topic!
White paper Reder
Through these high-value papers, we aspire to create a bridge of understanding between our team and our clients, fostering a relationship grounded in trust and mutual respect. It is our belief that by sharing our knowledge, we not only empower our clients but also contribute to the collective advancement of the precision medicine field. As we continue to explore new horizons and push the boundaries of what is possible, we invite our customers to join us in this journey, leveraging the expertise of preciSYN consultants as a key asset in their quest for innovation and excellence.

Download the knowledge

Each guide will be developed to serve as a standalone resource but, when combined, will offer a comprehensive portfolio for data management and data sovereignty in the realm of RWD and RWE. This portfolio will be invaluable for CROs, CDMOs, and other stakeholders involved in clinical research and laboratory research, ensuring they navigate the complexities of data management with confidence and compliance.

Out Now: Healthcare Interoperability

Guide to Data Capture and Remote Data Acquisition in Clinical Trials

Objective: To outline best practices for leveraging digital health technologies to enhance data capture and remote data acquisition in clinical settings, focusing on improving data quality, patient engagement, and operational efficiency.

Content: The guide will cover selecting appropriate digital technologies, ensuring data privacy and security, integrating systems for seamless data flow, and complying with regulatory standards. 

Download

Upcoming...

Guide for Creating a Value Chain of Data in Precision Medicine:

  • Objective: To provide a framework for creating a value chain that enhances the utility of data in precision medicine applications, from collection through analysis to actionable insights.

  • Content: This guide will discuss methods for data collection, storage, analysis, and interpretation, emphasizing the importance of data quality, interoperability, and the ethical use of patient data. 

In the Pipeline...

Our team is committed to not only compiling a portfolio of Guides specifically tailored for data management and data sovereignty in the realm of real-world data (RWD) and real-world evidence (RWE) within clinical research and research laboratories but also to distilling and consolidating essential information from the available resources.

  1. Guide to Ensuring Data Sovereignty in International Research Collaborations:

    • Objective: To address the challenges and solutions for maintaining data sovereignty in cross-border research collaborations, focusing on legal, ethical, and technical considerations.

    • Content: The guide will explore data residency laws, international data transfer mechanisms, consent management, and technologies that support data sovereignty, such as blockchain.

  2. Guide for Leveraging Real-World Evidence in Clinical Research:

    • Objective: To guide researchers and organizations in effectively using RWE to complement traditional clinical trial data, support regulatory submissions, and inform clinical practice.

    • Content: It will cover methodologies for generating RWE, integrating RWE with clinical trial data, ethical considerations, and case studies demonstrating the impact of RWE on healthcare decision-making.

  3. Guide to Data Privacy and Security in Clinical Research:

    • Objective: To provide a thorough overview of data privacy and security practices necessary to protect sensitive patient information in clinical research environments.

    • Content: Best practices for data encryption, access controls, audit trails, compliance with global data protection regulations (e.g., GDPR, HIPAA), and strategies for managing data breaches will be included.

  4. Guide to Data Management Practices for CRO and CDMO:

    • Objective: To offer comprehensive practices for managing data in CROs and CDMOs, ensuring integrity, confidentiality, and compliance with global data protection regulations.

    • Content: Topics will include data governance frameworks, roles and responsibilities for data management, standard operating procedures for data handling, and strategies for data sharing and collaboration.

Each guide will be developed to serve as a standalone resource but, when combined, will offer a comprehensive portfolio for data management and data sovereignty in the realm of RWD and RWE. This portfolio will be invaluable for CROs, CDMOs, and other stakeholders involved in clinical research and laboratory research, ensuring they navigate the complexities of data management with confidence and compliance.